local_hospital

Fertiliteitskliniek Twente B.V.

Address
lock Available on a paid plan

Fertiliteitskliniek Twente B.V.

Fertiliteitskliniek Twente B.V. is a specialized fertility clinic dedicated to advancing reproductive medicine through evidence-based clinical research. The center focuses on optimizing treatment protocols for couples experiencing difficulties conceiving, with particular expertise in investigating interventions that enhance pregnancy outcomes while maintaining cost-effectiveness.

  • Unexplained subfertility and infertility treatment optimization
  • Mild ovarian hyperstimulation with intra-uterine insemination (MOH/IUI) protocols
  • Progesterone luteal phase support efficacy research

The clinic's research portfolio demonstrates a commitment to evaluating both clinical efficacy and cost-effectiveness of fertility treatments. Their investigations include comprehensive assessments of hormonal support strategies, specifically examining progesterone luteal phase support in conjunction with FSH-based mild ovarian stimulation, with the ultimate goal of improving cumulative live birth rates for couples undergoing fertility treatment.

Site Overview

assignment
3
connected trials
corporate_fare
2
sponsors
science
4
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 271 other sites in The Netherlands

description
Trial volume
3
Outperforms 51% of sites
public
Therapeutic diversity
5areas
Outperforms 69% of sites
groups
Sponsor diversity
2sponsors
Outperforms 43% of sites

Therapeutic Area Benchmark — The Netherlands

Select a therapeutic area to compare against other sites in The Netherlands.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: The Netherlands

Market Share

Country: The Netherlands

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Fertiliteitskliniek Twente B.V.

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Letrozole Versus Gonadotropins for Ovulation Induction in Polycystic Ovary Syndrome: A Randomized Clinical TrialAmsterdam UMC StichtingPhase IIIRecruitingAug 2025

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Progesterone, Micronised2Unknown2023-03-062023-03-06

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.